Start-Up Execs On The Move, November 2012

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

Start-Up Execs

Caprotec bioanalytics GMBH

Jonathan Turner, PhD

To:Managing Dir. & CEO (October)

From:SVP, XL Techgroup

Tel:[phone]

Cebix Inc.

Joel Martin, PhD

To:Pres. & CEO (October)

From:Pres. & CEO, Altair Therapeutics Inc.

Tel:[phone]

Cerecor Inc.

John Kaiser

To:VP, Commercialization & Bus. Dev. (October)

From:Co-founder & CEO, Denysias Bioscience

Tel:[phone]

James Vornov, MD, PhD

To:SVP, Clinical Dev. & Regulatory Affairs (October)

From:Global Therapeutic Area Leader, CNS, Parexel International Corp.

Tel:[phone]

Coherus BioSciences Inc.

George G. Montgomery

To:CFO (October)

From:Managing Dir., Sagent Advisors LLC

Tel:[phone]

Fate Therapeutics Inc.

Christian Weyer, MD

To:Pres. & CEO (October)

From:SVP, R&D, Amylin Pharmaceuticals Inc.

Tel:[phone]

Igenica Inc.

Mary Haak-Frendscho, PhD

To:CEO (September)

From:Pres. & CSO, Takeda San Francisco

Tel:[phone]

Nivalis Therapeutics Inc.

Sherif Gabriel, PhD

To:VP, Research (October)

From:Dir., Cystic Fibrosis Correction Core, Cystic Fibrosis Center, University of North Carolina

Tel:[phone]

SpringLeaf Therapeutics Inc.

Pieter Muntendam, MD

To:Pres. & CEO (September)

From:EVP, CMO, BG Medicine Inc.

Tel:[phone]

Tolera Therapeutics Inc.

Linda C. Hogan

To:VP, Bus. Dev. (October)

From:Dir., Drug Information Services, University of Kansas School of Pharmacy & Kansas University Medical Center

Tel:[phone]

Start-Up Directors

ABT Molecular Imaging Inc.

Rik Vandevenne

To:Director (September)

Tel:[phone]

Aggredyne Inc.

Brady F. Carruth

To:Director (October)

Tel:[phone]

Edgar C. “Red” Griffin

To:Director (October)

Tel:[phone]

arGEN-X NV

David L. Lacey, MD

To:Director (October)

Tel:[phone]

Asceneuron SA

Frank Armstrong

To:Chairman (October)

Tel:[phone]

AyoxxA Biosystems GMBH

Rainer Christine

To:Chairman (September)

Tel:[phone]

Matthias Dill

To:Director (September)

Tel:[phone]

Regina Hodits

To:Director (September)

Tel:[phone]

Aristotelis Nastos

To:Director (September)

Tel:[phone]

Bind Biosciencs Inc.

Daniel S. Lynch

To:Chairman (September)

Tel:[phone]

Fedora Pharmaceuticals Inc.

Ronald W. Odynski

To:Director (October)

Tel:[phone]

Leonard E. Post, PhD

To:Director (October)

Tel:[phone]

GeneCentric Diagnostics Inc.

Arnold Levine, PhD

To:Director (September)

Tel:[phone]

Inspiration Biopharmaceuticals Inc.

Scott A. Canute

To:Director (September)

Tel:[phone]

Gino Santini

To:Director (September)

Tel:[phone]

Rheonix Inc.

Bill Colston, PhD

To:Director (October)

Tel:[phone]

Station X Inc.

Andre Bliznyuk

To:Director (September)

Tel:[phone]

Start-Up Investors

ORIX USA Health and Life Sciences LLC

John Amos

To:CEO (October)

From:Venture Partner, BioVeda China Fund

Tel:[phone]

Third Rock Ventures

Felix W. Frueh, PhD

To:Entrepreneur-in-Residence (October)

From:Pres., Medco Research Institute

Tel:[phone]

Start-Up Advisors

SpinalCyte LLC

Nicholas Theodore, MD

To:Clinical Advisor (October)

Tel:[phone]